β-amyloid catabolism:: roles for neprilysin (NEP) and other metallopeptidases?
β-amyloid catabolism:: roles for neprilysin (NEP) and other metallopeptidases?
复制标题
DOI:
10.1046/j.1471-4159.2002.00855.x
复制
发表时间:
2002-04-01
影响因子:
4.7
通讯作者:
Turner, AJ
中科院分区:
文献类型:
--
作者:
Carson, JA;Turner, AJ
The steady-state level of amyloid beta-peptide (Abeta) represents a balance between its biosynthesis from the amyloid precursor protein (APP) through the action of the beta- and gamma-secretases and its catabolism by a variety of proteolytic enzymes. Recent attention has focused on members of the neprilysin (NEP) family of zinc metalloproteinases in amyloid metabolism. NEP itself degrades both Abeta(1-40) and Abeta(1-42) in vitro and in vivo, and this metabolism is prevented by NEP inhibitors. Other NEP family members, for example endothelin-converting enzyme, may contribute to amyloid catabolism and may also play a role in neuroprotection. Another metalloproteinase, insulysin (insulin-degrading enzyme) has also been advocated as an amyloid-degrading enzyme and may contribute more generally to metabolism of amyloid-forming peptides. Other candidate enzymes proposed include angiotensin-converting enzyme, some matrix metalloproteinases, plasmin and, indirectly, thimet oligopeptidase (endopeptidase-24.15). This review critically evaluates the evidence relating to proteinases implicated in amyloid catabolism. Therapeutic strategies aimed at promoting Abeta degradation may provide a novel approach to the therapy of Alzheimer's disease.